Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial
Erratum

Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial

Wei-Jie Guan1#, Chun-Hua Wei2,3#, Ai-Lan Chen4,5#, Xiao-Cong Sun6,7, Guang-Yun Guo8, Xu Zou9,10, Jin-Dong Shi10,11, Pei-Zhen Lai12, Ze-Guang Zheng1, Nan-Shan Zhong1

1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China; 2Department of Respiratory Medicine, Weifang Wei’en Hospital, Weifang, China; 3Department of Respiratory Medicine, Wuhan Hanyang Hospital, Wuhan, China; 4Department of Cardiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China; 5Department of Respiratory and Critical Care Medicine, Wuhan Hankou Hospital, Wuhan, China; 6Intensive Care Unit, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China; 7Intensive Care Unit, Shishou Hospital of Traditional Chinese Medicine, Shishou, China; 8Department of Respiratory and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China; 9Department of Respiratory and Critical Care Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China; 10Department of Infectious Diseases, Leishenshan Hospital, Wuhan, China; 11Department of Respiratory and Critical Care Medicine, Shanghai Fifth People’s Hospital, Shanghai, China; 12Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei

#These authors contributed equally to this work.

Correspondence to: Nan-Shan Zhong. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, China. Email: nanshan@vip.163.com.

doi: 10.21037/jtd-2020-062


Erratum to: J Thorac Dis 2020;12:3448-52.


Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial

In the article that appeared on Page 3448-3452, Vol 12, No 6 (June 2020) Issue of the Journal of Thoracic Disease (JTD) (1), there is a numerical error occurred in the following sentence:

“On the basis of standard-of-care (3), patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 6 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditec Co., Ltd., China) daily until discharge [see Figure E1 in Online Supplement (http://dx.doi.org/10.21037/jtd-2020-057)].”

The number given as “6 L/min” should have been “3 L/min”. The sentence should read:

“On the basis of standard-of-care (3), patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 3 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditec Co., Ltd., China) daily until discharge [see Figure E1 in Online Supplement (http://dx.doi.org/10.21037/jtd-2020-057)].”

This numerical error does not affect the results or conclusions of the study.

The authors regret the error.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Guan WJ, Wei CH, Chen AL, et al. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis 2020;12:3448-52. [Crossref] [PubMed]
Cite this article as: Guan WJ, Wei CH, Chen AL, Sun XC, Guo GY, Zou X, Shi JD, Lai PZ, Zheng ZG, Zhong NS. Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis 2020;12(8):4591-4592. doi: 10.21037/jtd-2020-062